Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2025 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of Service
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to The Report
Fundraising

Brightside Health

Brightside Health Raises $105M in Series C

2019
Founded
400+
Employees
548 Market Street, San Francisco, CA 94104
Updated January 20, 2024
2 min read

Quick Facts

Brightside Health Raises $105M in Series C


Brightside Health has successfully raised $105M in a Series C at a $650M valuation led by Optum Ventures, Premera Blue Cross, Cigna Ventures, Threshold Ventures, Maveron.


Company Overview


Brightside Health is a HealthTech company headquartered in 548 Market Street, San Francisco, CA 94104, founded in 2019 with 400+ employees.


Virtual mental health care


Fundraising Details


  • Amount Raised: $105M
  • Round Type: Series C
  • Valuation: $650M
  • Date: 2024-01-20
  • Investors: Optum Ventures, Premera Blue Cross, Cigna Ventures, Threshold Ventures, Maveron

About Brightside Health


Virtual mental health care The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 548 Market Street, San Francisco, CA 94104
  • Founded: 2019
  • Team Size: 400+
  • Industry: HealthTech

What This Means


This funding round demonstrates strong investor confidence in Brightside Health's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Brightside Health's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $650M valuation marks an important milestone for Brightside Health, positioning the company among notable players in the HealthTech industry.


Looking Ahead


With this new capital, Brightside Health is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-20. For more information about Brightside Health, visit their headquarters at 548 Market Street, San Francisco, CA 94104.

Topics

Fundraising(2912)HealthTech(503)Series C(291)Brightside Health

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min readβ€’160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min readβ€’130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min readβ€’120 million